The government said on Tuesday that it has cleared 17 foreign direct investment proposals totaling Rs 262.56 crore, including that of Sanofi-Synthelabo (India).
The proposals were cleared following recommendations by the Foreign Investment Promotion Board (FIPB) headed by Arvind Mayaram, Secretary of the Department of Economic Affairs, an official statement said.
Sanofi-Synthelabo's proposal was regarding acquisition of a pharma company through internal accruals. The company proposes to bring in FDI worth Rs 180 crore. It further said decision on FDI proposals of Muthoot Finance Ltd to set up 'white label ATMs' has been deferred.
Also Read | Layoffs Are Rising In Tech, But These Skills Are Helping People Unlock Better Pay
A similar proposal of Euronet Services India to set up 'white label ATMs' was also deferred.
In all, seven pharmaceutical sector related proposals, including two applications of Oxford Lifesciences, have been cleared.
The government also gave its go ahead to a defence sector proposal of Pipavav Defence and Offshore Engineering Company. Augere Wireless Broadband's application to capitalise the balance amount of the spectrum fee earlier paid to DoT has been approved, the statement said.
The release further said the FDI proposal of Trakshun Management Consultants LLP has been rejected.
Decision on five other FDI proposals, including that of Mylan Laboratories and Empays Payment System India, has been deferred.
The FIPB had made the recommendations in its March meeting.
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.
